Mentor Injects Dermal Filler Pipeline With Genzyme R&D
This article was originally published in The Gray Sheet
Executive Summary
Mentor will market future Genzyme-developed hyaluronic acid dermal filler products to complement its existing Puragen hyaluronic acid device platform under a partnership agreement announced Oct. 30